NAMS Certification Exam 2026/2027 |
Verified Questions
Official Certification Board for Menopause and Women's Health | Verified Q&A | Healthcare
Providers and Women's Health Specialists
Introduction
This original 100-question practice examination covers Menopausal Physiology and Endocrinology, Hormone
Therapy and Pharmacological Management, Non-Hormonal Management and Lifestyle Interventions, and
Preventive Health, Screening, and Long-Term Wellness. It reinforces evidence-based care, patient-centered
counseling, rigorous risk assessment, and holistic midlife health to support exam readiness and academic success.
Accuracy note: The North American Menopause Society changed its name to The Menopause Society in 2023, and
the current credential is Menopause Society Certified Practitioner (MSCP), formerly NCMP. This user-titled “NAMS
Certification Exam” is independent practice material, not an official examination or board-endorsed product, and
no resource can guarantee certification or academic success.
Content Area Overview
Content Area Questions Key Topics Weight
Hormonal changes,
Menopausal Physiology
25 ovarian aging, VMS, GSM, 25%
and Endocrinology
metabolic shifts
Indications, routes,
Hormone Therapy and
regimens,
Pharmacological 25 25%
contraindications,
Management
pharmacology
Non-Hormonal CBT, medications,
Management and Lifestyle 25 lifestyle, complementary 25%
Interventions therapies, comorbidities
Preventive Health, Bone, cardiovascular,
Screening, and Long- 25 breast, screening, 25%
Term Wellness personalized prevention
NAMS Certification Exam 2026/2027
,Domain: Menopausal Physiology and Endocrinology
1. Which statement most accurately describes menopause clinical definition in evidence-based
menopause care?
A. Natural menopause is diagnosed retrospectively after 12 consecutive months of amenorrhea without another
pathologic or physiologic cause.
B. Menopause occurring from ages 40 through 44 is considered early and carries implications for bone,
cardiovascular, cognitive, and sexual health.
C. Menopause-related loss of lactobacilli and epithelial maturation commonly raises vaginal pH and increases
tissue fragility.
D. Lower estrogen and aging contribute to reduced dermal collagen, thickness, elasticity, and hydration.
Answer: A
Rationale: Natural menopause is diagnosed retrospectively after 12 consecutive months of amenorrhea without
another pathologic or physiologic cause. This reflects current menopause and women’s health guidance; patient-
specific evaluation, updated labeling, and shared decision-making remain essential.
2. Which statement most accurately describes STRAW+10 late transition in evidence-based
menopause care?
A. Bilateral oophorectomy causes an abrupt fall in ovarian hormones and may produce more sudden symptoms
than natural menopause.
B. Sexual desire is biopsychosocial and may be influenced by relationship factors, mood, medications, pain,
sleep, health, body image, and hormonal changes.
C. Pelvic floor symptoms reflect aging, childbirth, connective tissue, obesity, neurologic factors, and estrogen-
related tissue changes rather than estrogen loss alone.
D. The late menopausal transition is characterized by episodes of amenorrhea lasting 60 days or longer, with
increasingly variable ovarian function.
Answer: D
Rationale: The late menopausal transition is characterized by episodes of amenorrhea lasting 60 days or longer,
with increasingly variable ovarian function. This reflects current menopause and women’s health guidance;
patient-specific evaluation, updated labeling, and shared decision-making remain essential.
3. Which statement most accurately describes ovarian reserve decline in evidence-based
menopause care?
A. Vasomotor symptoms arise in part from narrowing of the hypothalamic thermoneutral zone associated with
estrogen withdrawal and neurokinin B signaling.
B. Accelerated bone loss follows estrogen deficiency because bone resorption increases more than bone
formation.
C. Ovarian aging reduces the follicle pool and inhibin B, contributing to rising follicle-stimulating hormone
before estradiol becomes consistently low.
D. Perimenopause is a window of increased vulnerability to depressive symptoms for some patients, especially
with prior depression, stress, sleep disturbance, and severe symptoms.
Answer: C
Rationale: Ovarian aging reduces the follicle pool and inhibin B, contributing to rising follicle-stimulating
hormone before estradiol becomes consistently low. This reflects current menopause and women’s health
guidance; patient-specific evaluation, updated labeling, and shared decision-making remain essential.
4. Which statement most accurately describes final menstrual period timing in evidence-based
menopause care?
A. A hot flash commonly begins with heat sensation and vasodilation, followed by sweating and sometimes
chills, palpitations, or anxiety.
B. The final menstrual period can be identified only retrospectively after the required amenorrhea interval.
C. Midlife is associated with increased visceral adiposity and reduced lean mass, influenced by aging,
menopause, activity, sleep, and energy balance.
D. Subjective “brain fog” is common in the transition, but persistent or progressive impairment requires
evaluation for sleep, mood, medications, medical illness, and neurologic disease.
Answer: B
Rationale: The final menstrual period can be identified only retrospectively after the required amenorrhea
interval. This reflects current menopause and women’s health guidance; patient-specific evaluation, updated
labeling, and shared decision-making remain essential.
5. Which statement most accurately describes FSH testing limitations in evidence-based
menopause care?
NAMS Certification Exam 2026/2027
, A. In a woman older than 45 with a typical menstrual history and symptoms, routine FSH measurement is
usually unnecessary because levels fluctuate during the transition.
B. Nighttime vasomotor symptoms can trigger awakenings, but insomnia may also have independent behavioral,
respiratory, mood, pain, or circadian contributors.
C. The menopause transition is commonly associated with increases in LDL cholesterol and other adverse lipid
changes, although aging and body composition also contribute.
D. Hormonal fluctuation can destabilize migraine during perimenopause; aura status and vascular risk are
important in treatment selection.
Answer: A
Rationale: In a woman older than 45 with a typical menstrual history and symptoms, routine FSH measurement
is usually unnecessary because levels fluctuate during the transition. This reflects current menopause and
women’s health guidance; patient-specific evaluation, updated labeling, and shared decision-making remain
essential.
6. Which statement most accurately describes premature ovarian insufficiency in evidence-based
menopause care?
A. Estrogen deficiency affects vulvar, vaginal, urethral, and bladder tissues, leading to dryness, burning,
dyspareunia, urinary symptoms, and recurrent infection risk.
B. Aging, visceral adiposity, sleep disruption, and reduced activity can worsen insulin resistance across midlife;
menopause is one contributor among several.
C. Heat intolerance, palpitations, sleep disturbance, and menstrual change can reflect thyroid disease, so
atypical symptoms warrant targeted evaluation.
D. Premature ovarian insufficiency involves loss or marked impairment of ovarian function before age 40 and
requires evaluation of pregnancy, endocrine causes, etiology, and long-term health effects.
Answer: D
Rationale: Premature ovarian insufficiency involves loss or marked impairment of ovarian function before age
40 and requires evaluation of pregnancy, endocrine causes, etiology, and long-term health effects. This reflects
current menopause and women’s health guidance; patient-specific evaluation, updated labeling, and shared
decision-making remain essential.
7. Which statement most accurately describes early menopause in evidence-based menopause care?
A. Unlike vasomotor symptoms, genitourinary syndrome commonly persists or progresses without treatment.
B. Lower estrogen and aging contribute to reduced dermal collagen, thickness, elasticity, and hydration.
C. Menopause occurring from ages 40 through 44 is considered early and carries implications for bone,
cardiovascular, cognitive, and sexual health.
D. Natural menopause is diagnosed retrospectively after 12 consecutive months of amenorrhea without another
pathologic or physiologic cause.
Answer: C
Rationale: Menopause occurring from ages 40 through 44 is considered early and carries implications for bone,
cardiovascular, cognitive, and sexual health. This reflects current menopause and women’s health guidance;
patient-specific evaluation, updated labeling, and shared decision-making remain essential.
8. Which statement most accurately describes surgical menopause in evidence-based menopause
care?
A. Menopause-related loss of lactobacilli and epithelial maturation commonly raises vaginal pH and increases
tissue fragility.
B. Bilateral oophorectomy causes an abrupt fall in ovarian hormones and may produce more sudden symptoms
than natural menopause.
C. Pelvic floor symptoms reflect aging, childbirth, connective tissue, obesity, neurologic factors, and estrogen-
related tissue changes rather than estrogen loss alone.
D. The late menopausal transition is characterized by episodes of amenorrhea lasting 60 days or longer, with
increasingly variable ovarian function.
Answer: B
Rationale: Bilateral oophorectomy causes an abrupt fall in ovarian hormones and may produce more sudden
symptoms than natural menopause. This reflects current menopause and women’s health guidance; patient-
specific evaluation, updated labeling, and shared decision-making remain essential.
9. Which statement most accurately describes vasomotor thermoregulation in evidence-based
menopause care?
A. Vasomotor symptoms arise in part from narrowing of the hypothalamic thermoneutral zone associated with
estrogen withdrawal and neurokinin B signaling.
NAMS Certification Exam 2026/2027
, B. Sexual desire is biopsychosocial and may be influenced by relationship factors, mood, medications, pain,
sleep, health, body image, and hormonal changes.
C. Perimenopause is a window of increased vulnerability to depressive symptoms for some patients, especially
with prior depression, stress, sleep disturbance, and severe symptoms.
D. Ovarian aging reduces the follicle pool and inhibin B, contributing to rising follicle-stimulating hormone
before estradiol becomes consistently low.
Answer: A
Rationale: Vasomotor symptoms arise in part from narrowing of the hypothalamic thermoneutral zone
associated with estrogen withdrawal and neurokinin B signaling. This reflects current menopause and women’s
health guidance; patient-specific evaluation, updated labeling, and shared decision-making remain essential.
10. Which statement most accurately describes hot-flash physiology in evidence-based menopause
care?
A. Accelerated bone loss follows estrogen deficiency because bone resorption increases more than bone
formation.
B. Subjective “brain fog” is common in the transition, but persistent or progressive impairment requires
evaluation for sleep, mood, medications, medical illness, and neurologic disease.
C. The final menstrual period can be identified only retrospectively after the required amenorrhea interval.
D. A hot flash commonly begins with heat sensation and vasodilation, followed by sweating and sometimes
chills, palpitations, or anxiety.
Answer: D
Rationale: A hot flash commonly begins with heat sensation and vasodilation, followed by sweating and
sometimes chills, palpitations, or anxiety. This reflects current menopause and women’s health guidance; patient-
specific evaluation, updated labeling, and shared decision-making remain essential.
11. Which statement most accurately describes sleep and vasomotor symptoms in evidence-based
menopause care?
A. Midlife is associated with increased visceral adiposity and reduced lean mass, influenced by aging,
menopause, activity, sleep, and energy balance.
B. Hormonal fluctuation can destabilize migraine during perimenopause; aura status and vascular risk are
important in treatment selection.
C. Nighttime vasomotor symptoms can trigger awakenings, but insomnia may also have independent behavioral,
respiratory, mood, pain, or circadian contributors.
D. In a woman older than 45 with a typical menstrual history and symptoms, routine FSH measurement is
usually unnecessary because levels fluctuate during the transition.
Answer: C
Rationale: Nighttime vasomotor symptoms can trigger awakenings, but insomnia may also have independent
behavioral, respiratory, mood, pain, or circadian contributors. This reflects current menopause and women’s
health guidance; patient-specific evaluation, updated labeling, and shared decision-making remain essential.
12. Which statement most accurately describes GSM pathophysiology in evidence-based menopause
care?
A. The menopause transition is commonly associated with increases in LDL cholesterol and other adverse lipid
changes, although aging and body composition also contribute.
B. Estrogen deficiency affects vulvar, vaginal, urethral, and bladder tissues, leading to dryness, burning,
dyspareunia, urinary symptoms, and recurrent infection risk.
C. Heat intolerance, palpitations, sleep disturbance, and menstrual change can reflect thyroid disease, so
atypical symptoms warrant targeted evaluation.
D. Premature ovarian insufficiency involves loss or marked impairment of ovarian function before age 40 and
requires evaluation of pregnancy, endocrine causes, etiology, and long-term health effects.
Answer: B
Rationale: Estrogen deficiency affects vulvar, vaginal, urethral, and bladder tissues, leading to dryness, burning,
dyspareunia, urinary symptoms, and recurrent infection risk. This reflects current menopause and women’s
health guidance; patient-specific evaluation, updated labeling, and shared decision-making remain essential.
13. Which statement most accurately describes GSM natural history in evidence-based menopause
care?
A. Unlike vasomotor symptoms, genitourinary syndrome commonly persists or progresses without treatment.
B. Aging, visceral adiposity, sleep disruption, and reduced activity can worsen insulin resistance across midlife;
menopause is one contributor among several.
NAMS Certification Exam 2026/2027
Verified Questions
Official Certification Board for Menopause and Women's Health | Verified Q&A | Healthcare
Providers and Women's Health Specialists
Introduction
This original 100-question practice examination covers Menopausal Physiology and Endocrinology, Hormone
Therapy and Pharmacological Management, Non-Hormonal Management and Lifestyle Interventions, and
Preventive Health, Screening, and Long-Term Wellness. It reinforces evidence-based care, patient-centered
counseling, rigorous risk assessment, and holistic midlife health to support exam readiness and academic success.
Accuracy note: The North American Menopause Society changed its name to The Menopause Society in 2023, and
the current credential is Menopause Society Certified Practitioner (MSCP), formerly NCMP. This user-titled “NAMS
Certification Exam” is independent practice material, not an official examination or board-endorsed product, and
no resource can guarantee certification or academic success.
Content Area Overview
Content Area Questions Key Topics Weight
Hormonal changes,
Menopausal Physiology
25 ovarian aging, VMS, GSM, 25%
and Endocrinology
metabolic shifts
Indications, routes,
Hormone Therapy and
regimens,
Pharmacological 25 25%
contraindications,
Management
pharmacology
Non-Hormonal CBT, medications,
Management and Lifestyle 25 lifestyle, complementary 25%
Interventions therapies, comorbidities
Preventive Health, Bone, cardiovascular,
Screening, and Long- 25 breast, screening, 25%
Term Wellness personalized prevention
NAMS Certification Exam 2026/2027
,Domain: Menopausal Physiology and Endocrinology
1. Which statement most accurately describes menopause clinical definition in evidence-based
menopause care?
A. Natural menopause is diagnosed retrospectively after 12 consecutive months of amenorrhea without another
pathologic or physiologic cause.
B. Menopause occurring from ages 40 through 44 is considered early and carries implications for bone,
cardiovascular, cognitive, and sexual health.
C. Menopause-related loss of lactobacilli and epithelial maturation commonly raises vaginal pH and increases
tissue fragility.
D. Lower estrogen and aging contribute to reduced dermal collagen, thickness, elasticity, and hydration.
Answer: A
Rationale: Natural menopause is diagnosed retrospectively after 12 consecutive months of amenorrhea without
another pathologic or physiologic cause. This reflects current menopause and women’s health guidance; patient-
specific evaluation, updated labeling, and shared decision-making remain essential.
2. Which statement most accurately describes STRAW+10 late transition in evidence-based
menopause care?
A. Bilateral oophorectomy causes an abrupt fall in ovarian hormones and may produce more sudden symptoms
than natural menopause.
B. Sexual desire is biopsychosocial and may be influenced by relationship factors, mood, medications, pain,
sleep, health, body image, and hormonal changes.
C. Pelvic floor symptoms reflect aging, childbirth, connective tissue, obesity, neurologic factors, and estrogen-
related tissue changes rather than estrogen loss alone.
D. The late menopausal transition is characterized by episodes of amenorrhea lasting 60 days or longer, with
increasingly variable ovarian function.
Answer: D
Rationale: The late menopausal transition is characterized by episodes of amenorrhea lasting 60 days or longer,
with increasingly variable ovarian function. This reflects current menopause and women’s health guidance;
patient-specific evaluation, updated labeling, and shared decision-making remain essential.
3. Which statement most accurately describes ovarian reserve decline in evidence-based
menopause care?
A. Vasomotor symptoms arise in part from narrowing of the hypothalamic thermoneutral zone associated with
estrogen withdrawal and neurokinin B signaling.
B. Accelerated bone loss follows estrogen deficiency because bone resorption increases more than bone
formation.
C. Ovarian aging reduces the follicle pool and inhibin B, contributing to rising follicle-stimulating hormone
before estradiol becomes consistently low.
D. Perimenopause is a window of increased vulnerability to depressive symptoms for some patients, especially
with prior depression, stress, sleep disturbance, and severe symptoms.
Answer: C
Rationale: Ovarian aging reduces the follicle pool and inhibin B, contributing to rising follicle-stimulating
hormone before estradiol becomes consistently low. This reflects current menopause and women’s health
guidance; patient-specific evaluation, updated labeling, and shared decision-making remain essential.
4. Which statement most accurately describes final menstrual period timing in evidence-based
menopause care?
A. A hot flash commonly begins with heat sensation and vasodilation, followed by sweating and sometimes
chills, palpitations, or anxiety.
B. The final menstrual period can be identified only retrospectively after the required amenorrhea interval.
C. Midlife is associated with increased visceral adiposity and reduced lean mass, influenced by aging,
menopause, activity, sleep, and energy balance.
D. Subjective “brain fog” is common in the transition, but persistent or progressive impairment requires
evaluation for sleep, mood, medications, medical illness, and neurologic disease.
Answer: B
Rationale: The final menstrual period can be identified only retrospectively after the required amenorrhea
interval. This reflects current menopause and women’s health guidance; patient-specific evaluation, updated
labeling, and shared decision-making remain essential.
5. Which statement most accurately describes FSH testing limitations in evidence-based
menopause care?
NAMS Certification Exam 2026/2027
, A. In a woman older than 45 with a typical menstrual history and symptoms, routine FSH measurement is
usually unnecessary because levels fluctuate during the transition.
B. Nighttime vasomotor symptoms can trigger awakenings, but insomnia may also have independent behavioral,
respiratory, mood, pain, or circadian contributors.
C. The menopause transition is commonly associated with increases in LDL cholesterol and other adverse lipid
changes, although aging and body composition also contribute.
D. Hormonal fluctuation can destabilize migraine during perimenopause; aura status and vascular risk are
important in treatment selection.
Answer: A
Rationale: In a woman older than 45 with a typical menstrual history and symptoms, routine FSH measurement
is usually unnecessary because levels fluctuate during the transition. This reflects current menopause and
women’s health guidance; patient-specific evaluation, updated labeling, and shared decision-making remain
essential.
6. Which statement most accurately describes premature ovarian insufficiency in evidence-based
menopause care?
A. Estrogen deficiency affects vulvar, vaginal, urethral, and bladder tissues, leading to dryness, burning,
dyspareunia, urinary symptoms, and recurrent infection risk.
B. Aging, visceral adiposity, sleep disruption, and reduced activity can worsen insulin resistance across midlife;
menopause is one contributor among several.
C. Heat intolerance, palpitations, sleep disturbance, and menstrual change can reflect thyroid disease, so
atypical symptoms warrant targeted evaluation.
D. Premature ovarian insufficiency involves loss or marked impairment of ovarian function before age 40 and
requires evaluation of pregnancy, endocrine causes, etiology, and long-term health effects.
Answer: D
Rationale: Premature ovarian insufficiency involves loss or marked impairment of ovarian function before age
40 and requires evaluation of pregnancy, endocrine causes, etiology, and long-term health effects. This reflects
current menopause and women’s health guidance; patient-specific evaluation, updated labeling, and shared
decision-making remain essential.
7. Which statement most accurately describes early menopause in evidence-based menopause care?
A. Unlike vasomotor symptoms, genitourinary syndrome commonly persists or progresses without treatment.
B. Lower estrogen and aging contribute to reduced dermal collagen, thickness, elasticity, and hydration.
C. Menopause occurring from ages 40 through 44 is considered early and carries implications for bone,
cardiovascular, cognitive, and sexual health.
D. Natural menopause is diagnosed retrospectively after 12 consecutive months of amenorrhea without another
pathologic or physiologic cause.
Answer: C
Rationale: Menopause occurring from ages 40 through 44 is considered early and carries implications for bone,
cardiovascular, cognitive, and sexual health. This reflects current menopause and women’s health guidance;
patient-specific evaluation, updated labeling, and shared decision-making remain essential.
8. Which statement most accurately describes surgical menopause in evidence-based menopause
care?
A. Menopause-related loss of lactobacilli and epithelial maturation commonly raises vaginal pH and increases
tissue fragility.
B. Bilateral oophorectomy causes an abrupt fall in ovarian hormones and may produce more sudden symptoms
than natural menopause.
C. Pelvic floor symptoms reflect aging, childbirth, connective tissue, obesity, neurologic factors, and estrogen-
related tissue changes rather than estrogen loss alone.
D. The late menopausal transition is characterized by episodes of amenorrhea lasting 60 days or longer, with
increasingly variable ovarian function.
Answer: B
Rationale: Bilateral oophorectomy causes an abrupt fall in ovarian hormones and may produce more sudden
symptoms than natural menopause. This reflects current menopause and women’s health guidance; patient-
specific evaluation, updated labeling, and shared decision-making remain essential.
9. Which statement most accurately describes vasomotor thermoregulation in evidence-based
menopause care?
A. Vasomotor symptoms arise in part from narrowing of the hypothalamic thermoneutral zone associated with
estrogen withdrawal and neurokinin B signaling.
NAMS Certification Exam 2026/2027
, B. Sexual desire is biopsychosocial and may be influenced by relationship factors, mood, medications, pain,
sleep, health, body image, and hormonal changes.
C. Perimenopause is a window of increased vulnerability to depressive symptoms for some patients, especially
with prior depression, stress, sleep disturbance, and severe symptoms.
D. Ovarian aging reduces the follicle pool and inhibin B, contributing to rising follicle-stimulating hormone
before estradiol becomes consistently low.
Answer: A
Rationale: Vasomotor symptoms arise in part from narrowing of the hypothalamic thermoneutral zone
associated with estrogen withdrawal and neurokinin B signaling. This reflects current menopause and women’s
health guidance; patient-specific evaluation, updated labeling, and shared decision-making remain essential.
10. Which statement most accurately describes hot-flash physiology in evidence-based menopause
care?
A. Accelerated bone loss follows estrogen deficiency because bone resorption increases more than bone
formation.
B. Subjective “brain fog” is common in the transition, but persistent or progressive impairment requires
evaluation for sleep, mood, medications, medical illness, and neurologic disease.
C. The final menstrual period can be identified only retrospectively after the required amenorrhea interval.
D. A hot flash commonly begins with heat sensation and vasodilation, followed by sweating and sometimes
chills, palpitations, or anxiety.
Answer: D
Rationale: A hot flash commonly begins with heat sensation and vasodilation, followed by sweating and
sometimes chills, palpitations, or anxiety. This reflects current menopause and women’s health guidance; patient-
specific evaluation, updated labeling, and shared decision-making remain essential.
11. Which statement most accurately describes sleep and vasomotor symptoms in evidence-based
menopause care?
A. Midlife is associated with increased visceral adiposity and reduced lean mass, influenced by aging,
menopause, activity, sleep, and energy balance.
B. Hormonal fluctuation can destabilize migraine during perimenopause; aura status and vascular risk are
important in treatment selection.
C. Nighttime vasomotor symptoms can trigger awakenings, but insomnia may also have independent behavioral,
respiratory, mood, pain, or circadian contributors.
D. In a woman older than 45 with a typical menstrual history and symptoms, routine FSH measurement is
usually unnecessary because levels fluctuate during the transition.
Answer: C
Rationale: Nighttime vasomotor symptoms can trigger awakenings, but insomnia may also have independent
behavioral, respiratory, mood, pain, or circadian contributors. This reflects current menopause and women’s
health guidance; patient-specific evaluation, updated labeling, and shared decision-making remain essential.
12. Which statement most accurately describes GSM pathophysiology in evidence-based menopause
care?
A. The menopause transition is commonly associated with increases in LDL cholesterol and other adverse lipid
changes, although aging and body composition also contribute.
B. Estrogen deficiency affects vulvar, vaginal, urethral, and bladder tissues, leading to dryness, burning,
dyspareunia, urinary symptoms, and recurrent infection risk.
C. Heat intolerance, palpitations, sleep disturbance, and menstrual change can reflect thyroid disease, so
atypical symptoms warrant targeted evaluation.
D. Premature ovarian insufficiency involves loss or marked impairment of ovarian function before age 40 and
requires evaluation of pregnancy, endocrine causes, etiology, and long-term health effects.
Answer: B
Rationale: Estrogen deficiency affects vulvar, vaginal, urethral, and bladder tissues, leading to dryness, burning,
dyspareunia, urinary symptoms, and recurrent infection risk. This reflects current menopause and women’s
health guidance; patient-specific evaluation, updated labeling, and shared decision-making remain essential.
13. Which statement most accurately describes GSM natural history in evidence-based menopause
care?
A. Unlike vasomotor symptoms, genitourinary syndrome commonly persists or progresses without treatment.
B. Aging, visceral adiposity, sleep disruption, and reduced activity can worsen insulin resistance across midlife;
menopause is one contributor among several.
NAMS Certification Exam 2026/2027
